Overview

Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma

Status:
Terminated

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the treatment of Yt90 Zevalin in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone)are effective as first line treatment in patients with bulky stage II or stage III or IV diffuse large B-cell lymphoma

Phase:

Phase 2

Details

Lead Sponsor:

Chulalongkorn University

Collaborator:

Bayer

Treatments:

Antibodies, Monoclonal